StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Dare Bioscience's enterprise value was -$2.09M on Nov 11, 2026, against $2.57M a year earlier. Over the last 5 years it ranged from -$2.09M to $411.24M, with a median of $25.08M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$2.09M-154.7%
2025Dec 31, 2025$3.82M-75.3%
2024Dec 31, 2024$15.43M-6.4%
2023Dec 29, 2023$16.48M-43.7%
2022Dec 30, 2022$29.29M-72.8%
2021Dec 31, 2021$107.64M+171.5%
2020Dec 31, 2020$39.64M+252.5%
2019Dec 31, 2019$11.25M–
2018Dec 31, 2018-$1.42M-131.2%
2017Dec 29, 2017$4.56M-76.5%
2016Dec 30, 2016$19.38M–
2015Dec 31, 2015-$1.06M-101.6%
2014Dec 31, 2014$67.39M–

More Dare Bioscience figures

See a number that looks wrong?